annual operating expenses:
$667.15M+$73.53M(+12.39%)Summary
- As of today (September 18, 2025), AMRX annual total operating expenses is $667.15 million, with the most recent change of +$73.53 million (+12.39%) on December 31, 2024.
- During the last 3 years, AMRX annual operating expenses has risen by +$99.80 million (+17.59%).
- AMRX annual operating expenses is now at all-time high.
Performance
AMRX Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$172.23M+$13.90M(+8.78%)Summary
- As of today (September 18, 2025), AMRX quarterly total operating expenses is $172.23 million, with the most recent change of +$13.90 million (+8.78%) on June 30, 2025.
- Over the past year, AMRX quarterly operating expenses has increased by +$19.71 million (+12.93%).
- AMRX quarterly operating expenses is now -5.86% below its all-time high of $182.95 million, reached on December 31, 2024.
Performance
AMRX quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AMRX Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.4% | +12.9% |
| 3 y3 years | +17.6% | +15.2% |
| 5 y5 years | +39.7% | +36.1% |
AMRX Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +17.6% | -5.9% | +22.3% |
| 5 y | 5-year | at high | +39.7% | -5.9% | +36.1% |
| alltime | all time | at high | >+9999.0% | -5.9% | >+9999.0% |
AMRX Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $172.23M(+8.8%) |
| Mar 2025 | - | $158.33M(-13.5%) |
| Dec 2024 | $667.15M(+12.4%) | $182.95M(+1.8%) |
| Sep 2024 | - | $179.79M(+17.9%) |
| Jun 2024 | - | $152.52M(+0.4%) |
| Mar 2024 | - | $151.89M(-2.1%) |
| Dec 2023 | $593.63M(-0.3%) | $155.09M(+0.5%) |
| Sep 2023 | - | $154.38M(+7.7%) |
| Jun 2023 | - | $143.37M(+1.8%) |
| Mar 2023 | - | $140.79M(-1.3%) |
| Dec 2022 | $595.39M(+4.9%) | $142.60M(-5.1%) |
| Sep 2022 | - | $150.31M(+0.5%) |
| Jun 2022 | - | $149.55M(-1.3%) |
| Mar 2022 | - | $151.46M(+1.6%) |
| Dec 2021 | $567.35M(+12.0%) | $149.10M(+6.3%) |
| Sep 2021 | - | $140.32M(+0.9%) |
| Jun 2021 | - | $139.02M(+0.1%) |
| Mar 2021 | - | $138.91M(+0.6%) |
| Dec 2020 | $506.66M(+6.1%) | $138.15M(+8.2%) |
| Sep 2020 | - | $127.64M(+0.9%) |
| Jun 2020 | - | $126.52M(+10.6%) |
| Mar 2020 | - | $114.36M(-6.4%) |
| Dec 2019 | $477.65M(+12.5%) | $122.13M(+19.8%) |
| Sep 2019 | - | $101.92M(-11.6%) |
| Jun 2019 | - | $115.30M(-16.6%) |
| Mar 2019 | - | $138.29M(+5.7%) |
| Dec 2018 | $424.63M(+51.4%) | $130.88M(+8.7%) |
| Sep 2018 | - | $120.37M(+16.5%) |
| Jun 2018 | - | $103.34M(+49.1%) |
| Mar 2018 | - | $69.33M(-1.6%) |
| Dec 2017 | $280.47M(-12.2%) | $70.46M(+2.5%) |
| Sep 2017 | - | $68.76M(-7.2%) |
| Jun 2017 | - | $74.12M(>+9900.0%) |
| Mar 2017 | - | $0.00(-100.0%) |
| Dec 2016 | $319.51M(+20.6%) | - |
| Dec 2016 | - | $70.39M(-4.3%) |
| Sep 2016 | - | $73.55M(+10.4%) |
| Jun 2016 | - | $66.65M(-40.1%) |
| Mar 2016 | - | $111.36M(+33.8%) |
| Dec 2015 | $264.97M(+21.3%) | $83.20M(+33.0%) |
| Sep 2015 | - | $62.54M(-4.2%) |
| Jun 2015 | - | $65.30M(+16.4%) |
| Mar 2015 | - | $56.12M(-5.4%) |
| Dec 2014 | $218.50M(+19.9%) | $59.34M(+2.5%) |
| Sep 2014 | - | $57.87M(+7.0%) |
| Jun 2014 | - | $54.07M(+14.5%) |
| Mar 2014 | - | $47.22M(+3.4%) |
| Dec 2013 | $182.18M(-4.0%) | $45.69M(+3.7%) |
| Sep 2013 | - | $44.04M(-9.8%) |
| Jun 2013 | - | $48.81M(-1.0%) |
| Mar 2013 | - | $49.32M(-12.0%) |
| Dec 2012 | $189.79M | $56.06M(+14.6%) |
| Sep 2012 | - | $48.94M(+9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $44.74M(+11.7%) |
| Mar 2012 | - | $40.05M(-1.0%) |
| Dec 2011 | $151.18M(+8.3%) | $40.46M(+15.1%) |
| Sep 2011 | - | $35.16M(-11.0%) |
| Jun 2011 | - | $39.49M(+9.5%) |
| Mar 2011 | - | $36.07M(-7.9%) |
| Dec 2010 | $139.56M(+35.5%) | $39.15M(+7.3%) |
| Sep 2010 | - | $36.48M(+10.1%) |
| Jun 2010 | - | $33.13M(+7.6%) |
| Mar 2010 | - | $30.79M(+25.0%) |
| Dec 2009 | $102.99M(-3.1%) | $24.64M(-1.8%) |
| Sep 2009 | - | $25.08M(-2.6%) |
| Jun 2009 | - | $25.75M(-6.4%) |
| Mar 2009 | - | $27.51M(+12.0%) |
| Dec 2008 | $106.31M(+33.6%) | $24.57M(-20.1%) |
| Sep 2008 | - | $30.73M(+18.7%) |
| Jun 2008 | - | $25.89M(+9.2%) |
| Mar 2008 | - | $23.70M(-6.0%) |
| Dec 2007 | $79.56M(+28.3%) | $25.21M(+31.9%) |
| Sep 2007 | - | $19.12M(+11.7%) |
| Jun 2007 | - | $17.11M(-5.6%) |
| Mar 2007 | - | $18.12M(+6.9%) |
| Dec 2006 | $62.00M(+19.6%) | $16.95M(+20.7%) |
| Sep 2006 | - | $14.05M(-14.7%) |
| Jun 2006 | - | $16.47M(+13.4%) |
| Mar 2006 | - | $14.53M(+18.9%) |
| Dec 2005 | $51.85M(+81.2%) | - |
| Sep 2004 | - | $12.22M(+7.0%) |
| Jun 2004 | - | $11.42M(+8.1%) |
| Mar 2004 | - | $10.57M(+24.7%) |
| Dec 2003 | $28.61M(+6.8%) | $8.47M(+21.5%) |
| Sep 2003 | - | $6.98M(+1.9%) |
| Jun 2003 | - | $6.85M(+8.6%) |
| Mar 2003 | - | $6.30M(+1.6%) |
| Dec 2002 | $26.78M(+44.5%) | $6.20M(-13.4%) |
| Sep 2002 | - | $7.16M(+3.8%) |
| Jun 2002 | - | $6.90M(+25.8%) |
| Mar 2002 | - | $5.49M(+13.3%) |
| Dec 2001 | $18.53M(+5.3%) | $4.84M(-6.3%) |
| Sep 2001 | - | $5.17M(+16.2%) |
| Jun 2001 | - | $4.45M(+9.1%) |
| Mar 2001 | - | $4.07M(+21.8%) |
| Dec 2000 | $17.60M(+111.8%) | $3.34M(-29.8%) |
| Sep 2000 | - | $4.76M(+7.8%) |
| Jun 2000 | - | $4.42M(+18.6%) |
| Mar 2000 | - | $3.72M(+234.9%) |
| Dec 1999 | $8.31M(+74.4%) | - |
| Sep 1999 | - | $1.11M(-9.7%) |
| Jun 1999 | - | $1.23M(-4.4%) |
| Mar 1999 | - | $1.29M(-4.7%) |
| Dec 1998 | $4.77M | $1.35M(+31.2%) |
| Sep 1998 | - | $1.03M(-21.2%) |
| Jun 1998 | - | $1.31M(+17.7%) |
| Mar 1998 | - | $1.11M |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual total operating expenses?
- What is the all time high annual operating expenses for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual operating expenses year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual total operating expenses?
The current annual operating expenses of AMRX is $667.15M
What is the all time high annual operating expenses for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual total operating expenses is $667.15M
What is Amneal Pharmaceuticals, Inc. annual operating expenses year-on-year change?
Over the past year, AMRX annual total operating expenses has changed by +$73.53M (+12.39%)
What is Amneal Pharmaceuticals, Inc. quarterly total operating expenses?
The current quarterly operating expenses of AMRX is $172.23M
What is the all time high quarterly operating expenses for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly total operating expenses is $182.95M
What is Amneal Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
Over the past year, AMRX quarterly total operating expenses has changed by +$19.71M (+12.93%)